HomeAPVO • NASDAQ
add
Aptevo Therapeutics Inc
Previous close
$1.13
Day range
$0.96 - $1.09
Year range
$0.67 - $80.96
Market cap
3.55M USD
Avg Volume
1.50M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.79M | -7.21% |
Net income | -5.90M | -27.17% |
Net profit margin | — | — |
Earnings per share | -6.46 | 86.10% |
EBITDA | -6.27M | 16.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 16.90M | -25.32% |
Total assets | 24.84M | -27.39% |
Total liabilities | 12.62M | -22.29% |
Total equity | 12.22M | — |
Shares outstanding | 533.46K | — |
Price to book | 0.04 | — |
Return on assets | -61.42% | — |
Return on capital | -82.71% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.90M | -27.17% |
Cash from operations | -5.25M | 11.55% |
Cash from investing | — | — |
Cash from financing | 3.05M | -49.22% |
Net change in cash | -2.21M | -3,840.68% |
Free cash flow | -3.96M | 35.49% |
About
Founded
2016
Headquarters
Website
Employees
40